Send us a link
A cross-sectional comparison of characteristics of potential predatory, legitimate open access, and legitimate subscription-based biomedical journals.
When Dr. Fraud applied to 360 randomly selected open-access academic journals asking to be an editor, 48 accepted her and four made her editor in chief.
The trend is indicative of a growing usage of general scientific jargon.
The French mathematician was cited “for his pivotal role in the development of the mathematical theory of wavelets.”
Scientists look to AI for help in peer review.
Would it be better to do away with the search for excellence, and to fund science by lottery?
In the latest ploy, a group of researchers in Poland tried to seat a fictional scholar onto the editorial boards of 360 academic publications.
European Digital City Index measures fertility of cities across Europe for innovative digital firms.
Conflicts of interest can send a researcher's reputation crashing — but resolving them needn't be as burdensome as it seems.
An investigation finds that dozens of academic titles offered 'Dr Fraud' — a sham, unqualified scientist — a place on their editorial board.
This is the second part in a series on how we edit science, looking at hypothesis testing, the problem of p-hacking and how the peer review process works.
Free online courses to help you expand your mind in whatever directions you want.
Editors are more likely to select reviewers of the same gender.
Carlos Moedas sees a bold future for the European Research Council and more projects that copy its approach.
Court documents suggest Monsanto helped “ghost write” paper
Broader forms of activism are needed to protect evidence-based policy.
Last year, NIH implemented a policy to push scientists to consider how sex affects biological systems. Critics worry it goes too far.
The region's scientists lament that their research is too often disconnected from the larger scientific world. In the age of Zika, that needs to change.
A study analysing digital transformation in the publishing industry found that 25 per cent of publishers see themselves as 'lagging' behind the rest of the industry.
Hundreds of researchers pick through clinical trial from a major blood-pressure study, to the dismay of some who collected the information.
